Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul;52(2):390-391.
doi: 10.1111/apt.15788.

Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease

Affiliations
Editorial

Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease

Jee-Fu Huang et al. Aliment Pharmacol Ther. 2020 Jul.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

REFERENCES

    1. Yu M-L, Huang C-F, Huang J-F, et al. Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients. Hepatology. 2011;53:7-13.
    1. Shen J, Wong GL, Chan HL, et al. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome. Aliment Pharmacol Ther. 2014;39:532-539.
    1. Wang C-W, Lin H-Y, Shin S-J, et al. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Liver Int. 2011;31:1326-1331.
    1. Trepo E, Valenti L. Update on NAFLD genetics: from new variants to the clinic. J Hepatol. 2020. https://doi.org/10.1016/j.jhep.2020.02.020. (In press).
    1. Mederacke Y, Kirstein MM, Großhennig A, et al. The PNPLA3 rs738409 GG genotype is associated with mortality in 239 patients with autoimmune hepatitis. Aliment Pharmacol Ther. 2020;51:1160-1168.

LinkOut - more resources